141 related articles for article (PubMed ID: 16254057)
1. Combined donor specific transfusion and anti-CD154 therapy achieves airway allograft tolerance.
Chalermskulrat W; McKinnon KP; Brickey WJ; Neuringer IP; Park RC; Sterka DG; Long BR; McNeillie P; Noelle RJ; Ting JP; Aris RM
Thorax; 2006 Jan; 61(1):61-7. PubMed ID: 16254057
[TBL] [Abstract][Full Text] [Related]
2. Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliteration.
Miller HL; Shah PD; Orens JB; McDyer JF
J Heart Lung Transplant; 2013 Sep; 32(9):914-24. PubMed ID: 23953819
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow.
Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T
J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779
[TBL] [Abstract][Full Text] [Related]
4. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
Zheng XX; Markees TG; Hancock WW; Li Y; Greiner DL; Li XC; Mordes JP; Sayegh MH; Rossini AA; Strom TB
J Immunol; 1999 Apr; 162(8):4983-90. PubMed ID: 10202046
[TBL] [Abstract][Full Text] [Related]
5. Virus-induced abrogation of transplantation tolerance induced by donor-specific transfusion and anti-CD154 antibody.
Welsh RM; Markees TG; Woda BA; Daniels KA; Brehm MA; Mordes JP; Greiner DL; Rossini AA
J Virol; 2000 Mar; 74(5):2210-8. PubMed ID: 10666251
[TBL] [Abstract][Full Text] [Related]
6. CD154 on the surface of CD4+CD25+ regulatory T cells contributes to skin transplant tolerance.
Jarvinen LZ; Blazar BR; Adeyi OA; Strom TB; Noelle RJ
Transplantation; 2003 Nov; 76(9):1375-9. PubMed ID: 14627918
[TBL] [Abstract][Full Text] [Related]
7. NOD mice have a generalized defect in their response to transplantation tolerance induction.
Markees TG; Serreze DV; Phillips NE; Sorli CH; Gordon EJ; Shultz LD; Noelle RJ; Woda BA; Greiner DL; Mordes JP; Rossini AA
Diabetes; 1999 May; 48(5):967-74. PubMed ID: 10331399
[TBL] [Abstract][Full Text] [Related]
8. Rat xenograft survival in mice treated with donor-specific transfusion and anti-CD154 antibody is enhanced by elimination of host CD4+ cells.
Gordon EJ; Woda BA; Shultz LD; Rossini AA; Greiner DL; Mordes JP
Transplantation; 2001 Jan; 71(2):319-27. PubMed ID: 11213080
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival of neonatal porcine islet xenografts in mice treated with a donor-specific transfusion and anti-CD154 antibody.
Appel MC; Banuelos SJ; Greiner DL; Shultz LD; Mordes JP; Rossini AA
Transplantation; 2004 May; 77(9):1341-9. PubMed ID: 15167588
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.
Kanzawa T; Hirai T; Fukuda H; Katsumata H; Ishii R; Ikemiyagi M; Ishii Y; Saiga K; Okumi M; Tanabe K
Acta Diabetol; 2019 May; 56(5):541-550. PubMed ID: 30758788
[TBL] [Abstract][Full Text] [Related]
11. Combined Anti-CD154/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts.
Lin CH; Wang YL; Anggelia MR; Chuang WY; Cheng HY; Mao Q; Zelken JA; Lin CH; Zheng XX; Lee WP; Brandacher G
Am J Transplant; 2016 Jul; 16(7):2030-41. PubMed ID: 26914847
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
Zhu ZX; Fan LY; Wang Q
Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
[TBL] [Abstract][Full Text] [Related]
13. Rapid dendritic cell activation and resistance to allotolerance induction in anti-CD154-treated mice receiving CD47-deficient donor-specific transfusion.
Wang Y; Wang H; Bronson R; Fu Y; Yang YG
Cell Transplant; 2014 Mar; 23(3):355-63. PubMed ID: 23295133
[TBL] [Abstract][Full Text] [Related]
14. Methyl-Guanine-Methyl-Transferase Transgenic Bone Marrow Transplantation Allows N,N-bis(2-chloroethyl)-Nitrosourea Driven Donor Mixed-Chimerism Without Graft-Versus-Host Disease, and With Donor-Specific Allograft Tolerance.
Hu M; Kramer B; Zhang GY; Wang YM; Watson D; Howden B; McCowage G; Alexander IE; Gunning P; Alexander SI
Transplantation; 2015 Dec; 99(12):2476-84. PubMed ID: 26177088
[TBL] [Abstract][Full Text] [Related]
15. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
16. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous donor marrow cell transplantation with reduced intensity conditioning prevents tracheal allograft obliteration in a bronchiolitis obliterans murine model.
Nusair S; Or R; Junadi S; Amir G; Breuer R
Chest; 2005 Dec; 128(6):4024-9. PubMed ID: 16354876
[TBL] [Abstract][Full Text] [Related]
18. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
Ringers J; Haanstra KG; Kroczek RA; Kliem K; Kuhn EM; Wubben J; Ossevoort MA; Volk HD; Jonker M
Transplantation; 2002 Mar; 73(6):862-6. PubMed ID: 11923684
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4(+) T cells, interferon-gamma, and CTLA4.
Markees TG; Phillips NE; Gordon EJ; Noelle RJ; Shultz LD; Mordes JP; Greiner DL; Rossini AA
J Clin Invest; 1998 Jun; 101(11):2446-55. PubMed ID: 9616216
[TBL] [Abstract][Full Text] [Related]
20. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
Cai Y; Zhou PJ; Tang XD
Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
